Skip to main content
SpringerLink
Log in

Reduced hsa-miR-124-3p levels are associated with the poor survival of patients with hepatocellular carcinoma

  • Original Article
  • Published:
Molecular Biology Reports Aims and scope Submit manuscript

Abstract

Hsa-MicroRNA-124a-3p (hsa-miR-124-3p) is involved in tumor progression in certain malignant tumors. However, its function and clinical implication in hepatocellular carcinoma (HCC) have not yet been illustrated. In this study, we explored the expression and prognostic value of hsa-miR-124-3p in patients with HCC. Hsa-miR-124-3p expression in HCC was analyzed in silico, which was subsequently confirmed by quantitative PCR in 155 HCC biopsy samples. Overall survival (OS) and disease-free survival in HCC patients was evaluated by Kaplan–Meier survival analysis, and univariate and multivariate Cox proportional hazard models were used. The in silico results demonstrated that hsa-miR-124-3p was reduced in cell lines and tissues of HCC, and hsa-miR-124-3p expression was lower in HCC tumor samples than in normal liver tissues. Moreover, a decrease in hsa-miR-124-3p expression was closely correlated with tumor diameter (≥ 5 cm) and number of lesions (multiple). Lower hsa-miR-124-3p expression was shown to be correlated with a shorter OS and poor prognosis in HCC. Our findings demonstrate that hsa-miR-124-3p might be a potential target for the diagnosis and prognosis of HCC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Wang Y, Ma YS, Fang Y, Wu SD, Liu LL, Fu D, Shen XZ (2012) Regulatory T cell: a protection for tumor cells. J Cell Mol Med 16(3):425–436

    Article  CAS  Google Scholar 

  2. Wu SD, Ma YS, Fu D, Shen XZ (2012) Role of the microenvironment in hepatocellular carcinoma development and progression. Cancer Treat Rev 38(3):218–225

    Article  CAS  Google Scholar 

  3. Liu LL, Fu D, Ma YS, Shen X (2011) The power and the promise of liver cancer stem cell markers. Stem Cells Dev 20(12):2023–2030

    Article  CAS  Google Scholar 

  4. Liang Z, Kong R, He Z, Lin LY, Qin SS, Chen CY, Xie ZQ, Yu F, Sun GQ, Li CG, Fu D, Jiang GX, Chen J, Ma YS (2017) High expression of miR-493-5p positively correlates with clinical prognosis of non small cell lung cancer by targeting oncogene ITGB1. Oncotarget 8(29):47389–47399

    PubMed  PubMed Central  Google Scholar 

  5. Hou LK, Ma YS, Han Y, Lu GX, Luo P, Chang ZY, Xie RT, Yang HQ, Chai L, Cai MX, Wu TM, Yu F, Qin SS, Lv ZW, Wu CY, Fu D (2017) Association of microRNA-33a molecular signature with non-small cell lung cancer diagnosis and prognosis after chemotherapy. PLoS ONE 12:e0170431

    Article  Google Scholar 

  6. Huang Q, Zhang XW, Ma YS, Lu GX, Xie RT, Yang HQ, Lv ZW, Zhong XM, Liu T, Huang SX, Fu D, Xie C (2017) Up-regulated microRNA-299 corrected with poor prognosis of glioblastoma multiforme patients by targeting ELL2. Jpn J Clin Oncol 47(7):590–596

    Article  Google Scholar 

  7. Luo P, Yang Q, Cong LL, Wang XF, Li YS, Zhong XM, Xie RT, Jia CY, Yang HQ, Li WP, Cong XL, Xia Q, Fu D, Zeng QH, Ma YS (2017) Identification of miR-124a as a novel diagnostic and prognostic biomarker in non-small cell lung cancer for chemotherapy. Mol Med Rep 16(1):238–246

    Article  CAS  Google Scholar 

  8. Lv H, Lv G, Han Q, Yang W, Wang H (2018) Noncoding RNAs in liver cancer stem cells: the big impact of little things. Cancer Lett 418:51–63

    Article  CAS  Google Scholar 

  9. Yang H, Li Y, Zhong X, Luo P, Luo P, Sun R, Xie R, Fu D, Ma Y, Cong X, Li W (2018) Upregulation of microRNA-32 is associated with tumorigenesis and poor prognosis in patients with hepatocellular carcinoma. Oncol Lett 15(4):4097–4104

    PubMed  PubMed Central  Google Scholar 

  10. Ma YS, Wu TM, Lv ZW, Lu GX, Cong XL, Xie RT, Yang HQ, Chang ZY, Sun R, Chai L, Cai MX, Zhong XJ, Zhu J, Fu D (2017) High expression of miR-105-1 positively correlates with clinical prognosis of hepatocellular carcinoma by targeting oncogene NCOA1. Oncotarget 8(7):11896–11905

    PubMed  PubMed Central  Google Scholar 

  11. Xie RT, Cong XL, Zhong XM, Luo P, Yang HQ, Lu GX, Luo P, Chang ZY, Sun R, Wu TM, Lv ZW, Fu D, Ma YS (2018) MicroRNA-33a downregulation is associated with tumorigenesis and poor prognosis in patients with hepatocellular carcinoma. Oncol Lett 15(4):4571–4577

    PubMed  PubMed Central  Google Scholar 

  12. Yuan J, Ji H, Xiao F, Lin Z, Zhao X, Wang Z, Zhao J, Lu J (2017) MicroRNA-340 inhibits the proliferation and invasion of hepatocellular carcinoma cells by targeting JAK1. Biochem Biophys Res Commun 483(1):578–584

    Article  CAS  Google Scholar 

  13. Dong Z, Qi R, Guo X, Zhao X, Li Y, Zeng Z, Bai W, Chang X, Hao L, Chen Y, Lou M, Li Z, Lu Y (2017) MiR-223 modulates hepatocellular carcinoma cell proliferation through promoting apoptosis via the Rab1-mediated mTOR activation. Biochem Biophys Res Commun 483(1):630–637

    Article  CAS  Google Scholar 

  14. Rajasethupathy P, Fiumara F, Sheridan R, Nazarian R, Betel D, Puthanveettil SV, Russo JJ, Sander C, Tuschl T, Kandel E (2009) Characterization of small RNAs in Apiysia reveals a role for miR-124 in constraining synaptic plasticity through CREB. Neuron 63:803–817

    Article  CAS  Google Scholar 

  15. Jazirehi AR, Torres-Collado AX, Nazarian R (2013) Epigenetic regulation of melanoma tumor suppressor miRNA-124a. Epigenomics 5(3):251–252

    Article  CAS  Google Scholar 

  16. Kynast KL, Russe OQ, Möser CV, Geisslinger G, Niederberger E (2013) Modulation of central nervous system-specific microRNA-124a alters the inflammatory response in the formalin test in mice. Pain 154(3):368–376

    Article  CAS  Google Scholar 

  17. Kawano S, Nakamachi Y (2011) hsa-miR-124-3p as a key regulator of proliferation and MCP-1 secretion in synoviocytes from patients with rheumatoid arthritis. Ann Rheum Dis 70:88–91

    Article  Google Scholar 

  18. Wang XF, Zhu YZ, Ma YS, Wang J, Zhang F, Xia Q, Fu D (2013) The role of cancer stem cells in cancer metastasis: new perspective and progress. Cancer Epidemiol 37(1):60–63

    Article  CAS  Google Scholar 

  19. Fu D, Ma YS, Wu W, Zhu XC, Jia CY, Zhao QL, Zhang CY, Wu XZ (2009) Cell-cycle-dependent PC-PLC regulation by APC/CCdc20-mediated ubiquitin-proteasome pathway. J Cell Biochem 107(4):686–696

    Article  CAS  Google Scholar 

  20. Ma YS, Huang T, Zhong XM, Zhang HW, Cong XL, Xu H, Lu GX, Yu F, Xue SB, Lv ZW, Fu D (2018) Proteogenomic characterization and comprehensive integrative genomic analysis of human colorectal cancer liver metastasis. Mol Cancer 17(1):139

    Article  Google Scholar 

  21. Fu XT, Shi YH, Zhou J, Peng YF, Liu WR, Shi GM, Gao Q, Wang XY, Song K, Fan J, Ding ZB (2018) MicroRNA-30a suppresses autophagy-mediated anoikis resistance and metastasis in hepatocellular carcinoma. Cancer Lett 412:108–117

    Article  CAS  Google Scholar 

  22. Chen X, Zhang S, Wang Z, Wang F, Cao X, Wu Q, Zhao C, Ma H, Ye F, Wang H, Fang Z (2018) Supervillin promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma in hypoxia via activation of the RhoA/ROCK-ERK/p38 pathway. J Exp Clin Cancer Res 37(1):128

    Article  Google Scholar 

  23. Yuan H, Li N, Fu D, Ren J, Hui J, Peng J, Liu Y, Qiu T, Jiang M, Pan Q, Han Y, Wang X, Li Q, Qin J (2017) Histone methyltransferase SETD2 modulates alternative splicing to inhibit intestinal tumorigenesis. J Clin Invest 127(9):3375–3391

    Article  Google Scholar 

  24. Yu J, Lei R, Zhuang X, Li X, Li G, Lev S, Segura MF, Zhang X, Hu G (2016) MicroRNA-182 targets SMAD7 to potentiate TGFβ-induced epithelial-mesenchymal transition and metastasis of cancer cells. Nat Commun 7:13884

    Article  CAS  Google Scholar 

  25. Shah R, Tanriverdi K, Levy D, Larson M, Gerstein M, Mick E, Rozowsky J, Kitchen R, Murthy V, Mikalev E, Freedman JE (2016) Discordant expression of circulating microRNA from cellular and extracellular sources. PLoS ONE 11:e0153691

    Article  Google Scholar 

  26. Cheng LC, Pastrana E, Tavazoie M, Doetsch F (2009) miR-124 regulates adult neurogenesis in the subventricular zone stem cell niche. Nat Neurosci 12(4):399–408

    Article  CAS  Google Scholar 

  27. Deng G, Kakar S, Kim YS (2011) MicroRNA-124a and microRNA-34b/c are frequently methylated in all histological types of colorectal cancer and polyps, and in the adjacent normal mucosa. Oncol Lett 2(1):175–180

    Article  CAS  Google Scholar 

  28. Chen X, He D, Dong XD, Dong F, Wang J, Wang L, Tang J, Hu DN, Yan D, Tu L (2013) MicroRNA-124a is epigenetically regulated and acts as a tumor suppressor by controlling multiple targets in uveal melanoma. Invest Ophthalmol Vis Sci 54(3):2248–2256

    Article  Google Scholar 

  29. Fowler A, Thomson D, Giles K, Maleki S, Mreich E, Wheeler H, Leedman P, Biggs M, Cook R, Little N, Robinson B, McDonald K (2011) hsa-miR-124-3p is frequently down-regulated in glioblastoma and is involved in migration and invasion. Eur J Cancer 47(6):953–963

    Article  CAS  Google Scholar 

  30. Zhao JJ, Lin J, Lwin T, Yang H, Guo J, Kong W, Dessureault S, Moscinski LC, Rezania D, Dalton WS, Sotomayor E, Tao J, Cheng JQ (2010) microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma. Blood 115(13):2630–2639

    Article  CAS  Google Scholar 

  31. Du X, Huo X, Yang Y, Hu Z, Botchway BOA, Jiang Y, Fang M (2017) miR-124 downregulates BACE 1 and alters autophagy in APP/PS1 transgenic mice. Toxicol Lett 280:195–205

    Article  CAS  Google Scholar 

  32. Ben Gacem R, Ben Abdelkrim O, Ziadi S, Ben Dhiab M, Trimeche M (2014) Methylation of hsa-miR-124-3p-1, hsa-miR-124-3p-2, and hsa-miR-124-3p-3 genes correlates with aggressive and advanced breast cancer disease. Tumour Biol 35(5):4047–4056

    Article  CAS  Google Scholar 

Download references

Funding

This study was supported partly by grants from the National Natural Science Foundation of China (81560053, 81772932, 81201535, 81302065, 81472202 and 81301993), the Youth Science and Technology Innovation Leading Talents Project of Corps (2017CB004), The Fundamental Research Funds for the Central Universities (22120170212 and 22120170117), Shanghai Natural Science Foundation (12ZR1436000), Shanghai Municipal Commission of Health and Family Planning (201540228), The peak of six personnel Foundation in Jiangsu Province (WSW-009) and The fifth phase of 333 talents Engineering Science and Technology Project of Jiangsu Province (BRA2017205).

Author information

Author notes

  1. Hui-Deng Long, Yu-Shui Ma and Hui-Qiong Yang have contributed equally to this work.

Authors and Affiliations

  1. Department of Pathology, Shihezi University School of Medicine, The First Affiliated Hospital of Shihezi University School of Medicine, Shihezi, 832003, Xinjiang, China

    Hui-Deng Long & Li-Juan Pang

  2. Shanghai Engineering Research Center of Molecular Therapeutics and New Drug Development, College of Chemistry and Molecular Engineering, East China Normal University, Shanghai, 200062, China

    Yu-Shui Ma

  3. Department of Nuclear Medicine, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai, 200072, China

    Yu-Shui Ma, Fei Yu, Zhong-Wei Lv, Gai-Xia Lu, Wen-Ting Xie & Da Fu

  4. Department of Pathology, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai, 200072, China

    Hui-Qiong Yang, Ru-Ting Xie & Zheng-Yan Chang

  5. Central Laboratory for Medical Research, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai, 200072, China

    Shao-Bo Xue, Ji-Yu Li & Da Fu

  6. Cancer Institute of Nantong Tumor Hospital, Nantong, 226631, China

    Ji-Bin Liu

Authors
  1. Hui-Deng Long
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yu-Shui Ma
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hui-Qiong Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Shao-Bo Xue
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ji-Bin Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Fei Yu
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Zhong-Wei Lv
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Ji-Yu Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Ru-Ting Xie
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Zheng-Yan Chang
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Gai-Xia Lu
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Wen-Ting Xie
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Da Fu
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Li-Juan Pang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Da Fu or Li-Juan Pang.

Ethics declarations

Conflict of interest

No potential conflicts of interest were disclosed.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Long, HD., Ma, YS., Yang, HQ. et al. Reduced hsa-miR-124-3p levels are associated with the poor survival of patients with hepatocellular carcinoma. Mol Biol Rep 45, 2615–2623 (2018). https://doi.org/10.1007/s11033-018-4431-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11033-018-4431-1

Keywords

Search

Navigation